Patients With High-grade Pancreatic Neuroendocrine Tumors

NCT07121478 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

46

Enrollment

OTHER_GOV

Sponsor class

Conditions

Neuroendocrine Tumor of Pancreas
Pancreatic Neuroendocrine Tumors

Interventions

DRUG: Lurbinectedin 4 MG Injection [Zepzelca]

Sponsor

National Cancer Center, Korea

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]